Open access
Aug 2026
Multi-omics identification of MBNL2 associated with poor pathological response to neoadjuvant chemoimmunotherapy in lung squamous cell carcinoma
A 25-gene prognostic model for LUSC is established and MBNL2 is identified as a novel correlate of poor pathological response to NACI, laying a foundation for future mechanistic investigation.
Hao Wu, Yang Cheng, Hong-Lin Yan et al.
· Frontiers in Oncology · 0 citations